Modulation of cardiac hypertrophy by estrogens

Area of Science:

• Molecular Endocrinology
• Cardiovascular Biology
• Genetics

Background:

• Gender-specific differences in heart disease are well-established.
• Steroid hormone mechanisms, particularly estrogens, are key to understanding these differences.
• Estrogen receptors (ERs) are nuclear proteins that act as transcription factors, influencing gene expression.

Purpose of the Study:

• To investigate the presence and function of estrogen receptors in the myocardium.
• To identify estrogen-responsive genes in cardiac cells.
• To explore the potential of estrogens in treating cardiac hypertrophy and failure.

Main Methods:

• Characterization of estrogen receptor presence in myocardial and cardiac fibroblast cells.
• Assessment of ER transcriptional activity using a luciferase reporter gene assay.
• Identification of estrogen-induced immediate-early and tissue-specific genes in the myocardium.

Main Results:

• Estrogen receptors were identified and confirmed to be transcriptionally active in the heart.
• Estradiol was shown to induce specific immediate-early genes and tissue-specific genes in the myocardium.
• Estrogen signaling pathways in the heart are being elucidated.

Conclusions:

• Estrogen receptors play a functional role in the myocardium.
• Estrogen's influence on cardiac gene expression offers potential therapeutic targets for heart disease.
• Further research into estrogen's role in cardiac hypertrophy and failure is warranted.